Multi-Omics Integration Strategies: Principles, Computational Frameworks, and Applications in Veterinary Systems Biology
Introduction
The advent of high-throughput molecular technologies has enabled the simultaneous measurement of thousands of biological molecules across multiple functional layers. In veterinary medicine, these layers include the genome (DNA sequence variation), epigenome (DNA methylation and histone modifications), transcriptome (RNA expression), proteome (protein abundance and post-translational modifications), metabolome (small molecule metabolites), and microbiome (composition and function of microbial communities). Each individual omics layer provides a partial view of the biological system under investigation. The central challenge in systems biology is to integrate these disparate data types into coherent models that capture the emergent properties of host-pathogen interactions, disease progression, and treatment response.
Multi-omics integration strategies aim to overcome the limitations of single-omics analyses by leveraging complementary information. For example, a genomic variant associated with susceptibility to a pathogen may only exert its phenotypic effect through altered gene expression, which can be detected at the transcriptomic level. Similarly, a change in metabolite abundance may be explained by alterations in enzyme abundance (proteomics) or by post-translational modifications that affect enzyme activity. Integration strategies seek to identify these causal chains and to construct predictive models that are more robust and biologically interpretable than those derived from any single data type.
This article provides a detailed technical review of multi-omics integration strategies relevant to veterinary diagnostics and research. It covers the types of omics data commonly generated, the computational frameworks used for integration, and the specific applications in host-pathogen systems, with a focus on livestock, poultry, and companion animals. The discussion is grounded in the biophysical and biochemical principles underlying each data type and the mathematical foundations of the integration algorithms.
Types of Omics Data in Veterinary Systems
Genomics
Genomics encompasses the study of the complete DNA sequence of an organism. In veterinary contexts, genomic data are typically generated using high-throughput sequencing platforms or genotyping arrays. Key applications include the identification of single nucleotide polymorphisms (SNPs), copy number variants (CNVs), and structural variants associated with disease resistance or susceptibility. For example, specific alleles of the major histocompatibility complex (MHC) genes in chickens have been associated with resistance to Marek's disease virus. Genomic data are inherently static; they do not change with physiological state or infection status, making them a stable reference layer for integration.
Epigenomics
Epigenomics refers to the genome-wide mapping of chemical modifications to DNA and histone proteins that regulate gene expression without altering the underlying DNA sequence. The most studied epigenetic mark is DNA methylation at cytosine-guanine dinucleotides (CpG sites). In veterinary species, epigenetic changes have been documented in response to nutritional stress, environmental toxins, and pathogen infection. For instance, infection with Feline Leukemia Virus can induce methylation changes in host tumor suppressor genes. Epigenomic data are typically generated using bisulfite sequencing or chromatin immunoprecipitation followed by sequencing (ChIP-seq).
Transcriptomics
Transcriptomics measures the abundance of RNA transcripts, including messenger RNA (mRNA), non-coding RNA, and small RNA species. The most common platform is RNA sequencing (RNA-seq), which provides both quantitative expression data and sequence information for splice variant detection. Transcriptomic data are highly dynamic and reflect the immediate response of the host to infection, inflammation, or treatment. In veterinary diagnostics, transcriptomic signatures have been developed for the early detection of subclinical mastitis in dairy cattle and for differentiating between viral and bacterial respiratory infections in swine.
Proteomics
Proteomics involves the large-scale identification and quantification of proteins. The primary analytical platform is liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Proteomic data provide information on protein abundance, post-translational modifications (e.g., phosphorylation, glycosylation), and protein-protein interactions. Because proteins are the functional effectors of most biological processes, proteomic data often correlate more directly with phenotype than transcriptomic data. However, the dynamic range of protein abundance in biological samples is vast, and detection of low-abundance proteins remains technically challenging.
Metabolomics
Metabolomics measures the complete set of small molecule metabolites (molecular weight less than 1500 Da) in a biological sample. The two main analytical platforms are nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry coupled to liquid or gas chromatography (LC-MS, GC-MS). Metabolites are the end products of cellular regulatory processes, and their levels provide a direct readout of the physiological state of the organism. In veterinary medicine, metabolomic profiling has been used to identify biomarkers for ketosis in dairy cows, for liver fluke infection (see Fasciolosis in Cattle and Sheep), and for Canine Parvovirus infection severity.
Microbiomics
Microbiomics refers to the characterization of microbial communities inhabiting a host, typically through amplicon sequencing of the 16S ribosomal RNA gene (for bacteria) or internal transcribed spacer (ITS) region (for fungi), or through shotgun metagenomic sequencing. The microbiome interacts with the host immune system and metabolism, and alterations in microbial composition have been linked to diseases such as Necrotic Enteritis in Broiler Chickens and Swine Gut Microbiota and Bacterial Pathogens.
Computational Frameworks for Multi-Omics Integration
Integration strategies can be broadly classified into three categories: concatenation-based, transformation-based, and model-based approaches. Each category has distinct mathematical foundations and is suited to different types of biological questions.
Concatenation-Based Integration
In concatenation-based integration, data from multiple omics layers are combined into a single matrix before analysis. This approach is conceptually simple and allows the application of standard machine learning algorithms. However, it requires careful normalization to ensure that each omics layer contributes equally to the analysis. Common normalization strategies include z-score scaling, quantile normalization, and variance-stabilizing transformations.
A major challenge with concatenation is the "curse of dimensionality": the number of features (e.g., genes, proteins, metabolites) often far exceeds the number of samples, leading to overfitting. Dimensionality reduction techniques such as principal component analysis (PCA) or t-distributed stochastic neighbor embedding (t-SNE) are frequently applied before concatenation to reduce the feature space. Alternatively, feature selection methods such as LASSO (least absolute shrinkage and selection operator) or random forest variable importance can be used to identify the most informative features from each omics layer.
Transformation-Based Integration
Transformation-based methods convert each omics dataset into a common representation, such as a kernel matrix or a graph, before combining them. Kernel methods, for example, compute pairwise similarity matrices for each omics layer and then combine these matrices through weighted averaging or multiple kernel learning. The combined kernel can then be used with support vector machines or kernel PCA for classification or clustering.
Another transformation-based approach is network fusion, where each omics layer is represented as a graph (nodes are genes or proteins, edges represent correlations or known interactions). These graphs are then merged into a single consensus network using algorithms such as similarity network fusion (SNF). The resulting network can be used to identify disease modules or to stratify patients into subtypes.
Model-Based Integration
Model-based approaches explicitly model the relationships between omics layers using statistical or mechanistic models. These methods are more interpretable than concatenation or transformation approaches but require stronger assumptions about the underlying biology.
One common model-based approach is canonical correlation analysis (CCA) and its extensions, such as sparse CCA and kernel CCA. CCA identifies linear combinations of variables from two omics datasets that are maximally correlated. For example, CCA can be used to find pairs of transcriptomic and proteomic features that covary across samples. Sparse CCA adds a penalty term to select only a subset of features, improving interpretability.
Another powerful model-based method is the use of Bayesian networks. Bayesian networks represent causal relationships between variables as directed acyclic graphs. In a multi-omics context, a Bayesian network can model the flow of information from genotype to transcript to protein to metabolite, allowing inference of causal pathways. The structure of the network can be learned from data using score-based or constraint-based algorithms, or it can be specified based on prior biological knowledge.
Deep Learning Approaches
Deep learning methods, particularly autoencoders and variational autoencoders, have been applied to multi-omics integration. An autoencoder is a neural network that learns a compressed representation (latent space) of the input data. In multi-omics integration, each omics layer can be passed through its own encoder, and the latent representations are then combined and passed through a joint decoder. This architecture, known as a multi-modal autoencoder, can capture non-linear relationships between omics layers. Variational autoencoders add a probabilistic component, allowing the model to generate new samples and to quantify uncertainty.
Workflow for Multi-Omics Integration in Veterinary Diagnostics
The following Mermaid diagram illustrates a typical workflow for multi-omics integration in a veterinary diagnostic context, using a host-pathogen interaction study as an example.
flowchart TD
A[Sample Collection], > B[Omics Data Generation]
B, > C1[Genomics: WGS or Genotyping Array]
B, > C2[Transcriptomics: RNA-seq]
B, > C3[Proteomics: LC-MS/MS]
B, > C4[Metabolomics: NMR or LC-MS]
B, > C5[Microbiomics: 16S rRNA Amplicon Sequencing]
C1, > D[Quality Control and Normalization]
C2, > D
C3, > D
C4, > D
C5, > D
D, > E[Feature Selection and Dimensionality Reduction]
E, > F[Integration Strategy Selection]
F, > G1[Concatenation-Based]
F, > G2[Transformation-Based]
F, > G3[Model-Based]
G1, > H[Multi-Omics Model Construction]
G2, > H
G3, > H
H, > I[Model Validation and Interpretation]
I, > J[Biomarker Discovery]
I, > K[Pathway Analysis]
I, > L[Disease Subtyping]
J, > M[Clinical Translation]
K, > M
L, > M
Applications in Veterinary Host-Pathogen Systems
Identification of Biomarkers for Infectious Diseases
Multi-omics integration has been used to identify composite biomarkers that outperform single-omics markers in diagnostic accuracy. For example, in bovine respiratory disease complex (BRDC), integration of transcriptomic and metabolomic data from bronchoalveolar lavage fluid has identified a panel of 15 genes and 8 metabolites that distinguish infected from healthy animals with high sensitivity and specificity. The transcriptomic component captures the host immune response, while the metabolomic component reflects the metabolic perturbations caused by the pathogen.
In poultry, integration of genomic and transcriptomic data has been used to identify genetic variants that regulate the expression of immune-related genes during infection with Highly Pathogenic Avian Influenza (H5N1). These expression quantitative trait loci (eQTLs) provide targets for selective breeding of more resistant lines.
Elucidation of Pathogenesis Mechanisms
Multi-omics integration can reveal the molecular mechanisms by which pathogens subvert host defenses. For instance, in Mycoplasma bovis infection in feedlot cattle, integration of proteomic and metabolomic data from lung tissue has shown that the pathogen induces a shift from oxidative phosphorylation to glycolysis in host cells, a phenomenon known as the Warburg effect. This metabolic reprogramming is accompanied by changes in the abundance of proteins involved in the tricarboxylic acid cycle and the electron transport chain.
In Ehrlichia canis infection in dogs, integration of transcriptomic and epigenomic data has revealed that the pathogen induces DNA methylation changes in the promoters of genes encoding cytokines and chemokines, leading to a dysregulated immune response. These epigenetic marks persist after treatment and may contribute to chronic disease.
Disease Subtyping and Prognosis
Multi-omics integration can stratify animals into clinically relevant subtypes that are not apparent from any single data type. In Canine Coronavirus infection, integration of viral genomic data with host transcriptomic data has identified two distinct subtypes: one associated with enteric disease and a second associated with pantropic disease. The pantropic subtype is characterized by a distinct host gene expression signature involving upregulation of genes involved in vascular permeability and coagulation.
In Feline Coronavirus infection, integration of host transcriptomic and metabolomic data has been used to predict progression from mild enteritis to fatal feline infectious peritonitis (FIP). A logistic regression model combining expression levels of three immune-related genes and serum concentrations of two metabolites achieved an area under the receiver operating characteristic curve (AUC) of 0.92 in a validation cohort.
Antimicrobial Resistance Surveillance
Integration of genomic and transcriptomic data can provide insights into the mechanisms of antimicrobial resistance in veterinary pathogens. For example, in Staphylococcus aureus isolates from bovine mastitis cases, integration of whole-genome sequencing data with RNA-seq data has identified novel regulatory RNAs that control the expression of resistance genes. These RNAs represent potential targets for adjunctive therapies that could restore susceptibility to existing antibiotics.
In Escherichia coli isolates from poultry, integration of genomic and metabolomic data has shown that resistance to fluoroquinolones is associated with specific metabolic signatures, including increased flux through the pentose phosphate pathway. These metabolic signatures could be used as phenotypic markers for rapid resistance screening.
Challenges and Limitations
Data Heterogeneity and Batch Effects
Omics data are generated using different platforms, protocols, and laboratories, leading to systematic technical variation known as batch effects. These effects can obscure biological signals and lead to false discoveries if not properly addressed. Common correction methods include ComBat, limma, and Harmony. However, these methods assume that batch effects are additive and independent of biological variation, an assumption that may not hold in all cases.
Missing Data
Multi-omics studies often suffer from missing data, where certain omics layers are not measured for all samples due to cost constraints, sample quantity limitations, or technical failures. Missing data can be handled through imputation (e.g., using k-nearest neighbors or matrix factorization) or through model-based approaches that can accommodate missing values, such as probabilistic principal component analysis.
Interpretability
Deep learning models, while powerful, are often criticized for their lack of interpretability. In a veterinary diagnostic context, clinicians and regulators require models that can be explained in biological terms. Techniques such as SHAP (SHapley Additive exPlanations) and LIME (Local Interpretable Model-agnostic Explanations) can provide feature-level explanations for individual predictions, but they do not reveal the underlying causal mechanisms.
Computational Cost
Integration of large-scale omics datasets requires substantial computational resources. For example, training a multi-modal autoencoder on a dataset with 1000 samples and 50,000 features across four omics layers can require several hours on a high-performance computing cluster. Cloud-based solutions and GPU acceleration can mitigate this challenge but increase the cost and complexity of the analysis.
Future Directions
Single-Cell Multi-Omics
The development of single-cell technologies, such as single-cell RNA-seq (scRNA-seq), single-cell ATAC-seq (scATAC-seq), and CITE-seq (cellular indexing of transcriptomes and epitopes by sequencing), has enabled the measurement of multiple omics layers in individual cells. Integration of single-cell multi-omics data can reveal cell-type-specific responses to infection and identify rare cell populations that drive disease pathogenesis. In veterinary medicine, single-cell approaches have been applied to study the immune response to Avian Influenza in chicken lung tissue and to characterize the tumor microenvironment in canine mammary carcinoma.
Spatial Omics
Spatial transcriptomics and spatial proteomics technologies preserve the spatial context of molecular measurements within tissue sections. Integration of spatial omics data with other omics layers can provide insights into the organization of host-pathogen interactions at the tissue level. For example, in Mycobacterium avium subsp. avium infection in poultry, spatial transcriptomics has revealed the formation of granulomas with distinct transcriptional zones, including a core of infected macrophages surrounded by a ring of activated T cells.
Longitudinal Multi-Omics
Longitudinal studies that collect multiple omics data types at multiple time points during infection or treatment can capture the dynamic nature of host-pathogen interactions. Integration of longitudinal data requires specialized methods, such as dynamic Bayesian networks or functional data analysis, that can model temporal dependencies. In Teladorsagia circumcincta infection in sheep, longitudinal integration of fecal egg counts, plasma metabolomics, and abomasal transcriptomics has identified a time-dependent shift from a Th2 to a Th17 immune response that correlates with the development of anthelmintic resistance.
Conclusion
Multi-omics integration strategies represent a powerful approach for understanding the complex biological systems underlying veterinary diseases. By combining data from genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics, these strategies can identify biomarkers, elucidate pathogenesis mechanisms, and stratify disease subtypes with greater accuracy than single-omics approaches. The choice of integration strategy depends on the biological question, the nature of the data, and the available computational resources. As single-cell and spatial technologies mature, and as longitudinal studies become more common, the field of multi-omics integration will continue to evolve, offering new opportunities for improving veterinary diagnostics and therapeutics.
References
- Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biology. 2017;18(1):83.
- Subramanian I, Verma S, Kumar S, Jere A, Anamika K. Multi-omics data integration, interpretation, and its application. Bioinformatics and Biology Insights. 2020;14:1177932219899051.
- Ritchie MD, Holzinger ER, Li R, Pendergrass SA, Kim D. Methods of integrating data to uncover genotype-phenotype interactions. Nature Reviews Genetics. 2015;16(2):85-97.
- Wang B, Mezlini AM, Demir F, Fiume M, Tu Z, Brudno M, et al. Similarity network fusion for aggregating data types on a genomic scale. Nature Methods. 2014;11(3):333-337.
- Argelaguet R, Velten B, Arnol D, Dietrich S, Zenz T, Marioni JC, et al. Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets. Molecular Systems Biology. 2018;14(6):e8124.
- Rohart F, Gautier B, Singh A, Le Cao KA. mixOmics: An R package for 'omics feature selection and multiple data integration. PLoS Computational Biology. 2017;13(11):e1005752.
- Zitnik M, Zupan B. Data fusion by matrix factorization. IEEE Transactions on Pattern Analysis and Machine Intelligence. 2015;37(1):41-53.
- Gligorijevic V, Malod-Dognin N, Przulj N. Integrative methods for analyzing big data in precision medicine. Proteomics. 2016;16(5):741-758.
- Bersanelli M, Mosca E, Remondini D, Giampieri E, Sala C, Castellani G, et al. Methods for the integration of multi-omics data: mathematical aspects. BMC Bioinformatics. 2016;17(Suppl 2):S15.
- Huang S, Chaudhary K, Garmire LX. More is better: recent progress in multi-omics data integration methods. Frontiers in Genetics. 2017;8:84.